| Eribulin Mesylate |
Metastatic Breast Cancer, Liposarcoma |
Eisai |
Halaven® |
| Lifitegrast |
Dry Eye Disease |
Sunesis/Shire |
Xiidra® |
| Naldemedine Tosylate |
Opioid-Induced Constipation |
BioDelivery Sciences/Shionogi |
Symproic® |
| Netarsudil Dimesylate |
Antiglaucoma |
Aerie Pharmaceuticals |
Phopressa®/Rhokiinsa® |
| Latanoprostene Bunod |
Antiglaucoma |
Valeant/B&L |
Vyzulta® |
| Naloxegol Oxalate |
Opioid-Induced Constipation |
Redhill Biopharma/AstraZeneca |
Movantik®/Moventig® |
| Lenvatinib Mesylate |
Differentiated Thyroid Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma |
Eisai |
Lenvima® |
| Relugolix |
Prostate Cancer (US), Uterine Leiomyomas (Japan) |
Takeda/Myovant Sciences |
Orgovyx® (US)/Relumina® (Japan) |
| Teneligliptin Hydrobromide |
Type 2 Diabetes |
Mitsubishi-Tanabe |
Tenelia® |
